GT BIOPHARMA
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immunology therapeutic products based on our proprietary Trispecific Killer Engagers (TriKE™) target-directed Natural Killer (NK) cell engager platform. The TriKE™ NK protein biologic platform is designed to harness and amplify the body’s native immune system for hope for patients with cancer and infectious diseases.
GT BIOPHARMA
Industry:
Biotechnology Health Care Medical
Founded:
1965-01-01
Address:
Westlake Village, California, United States
Country:
United States
Website Url:
http://www.gtbiopharma.com
Total Employee:
1+
Status:
Active
Contact:
310-860-5184
Total Funding:
88.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Apache Microsoft Exchange Online Amazon
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2005-09-21 | BioCheck | BioCheck acquired by GT Biopharma | 6 M USD |
| 1998-01-06 | Innovative Medical Systems | Innovative Medical Systems acquired by GT Biopharma | N/A |
Investors List
Armando Soto
Armando Soto investment in Post-IPO Equity - GT Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-18 | GT Biopharma Appoints Manu Ohri as Chief Financial Officer |
Official Site Inspections
http://www.gtbiopharma.com
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
